These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9187133)
1. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Soukka T; Salmi M; Joensuu H; Häkkinen L; Sointu P; Koulu L; Kalimo K; Klemi P; Grénman R; Jalkanen S Cancer Res; 1997 Jun; 57(11):2281-9. PubMed ID: 9187133 [TBL] [Abstract][Full Text] [Related]
2. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN; Mirejovský T; Melinová L; Mandys V Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866 [TBL] [Abstract][Full Text] [Related]
3. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck. Boldrup L; Coates PJ; Gu X; Nylander K J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789 [TBL] [Abstract][Full Text] [Related]
5. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348 [TBL] [Abstract][Full Text] [Related]
7. CD44 and its v6 spliced variant in lung tumors: a role in histogenesis? Fasano M; Sabatini MT; Wieczorek R; Sidhu G; Goswami S; Jagirdar J Cancer; 1997 Jul; 80(1):34-41. PubMed ID: 9210706 [TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium. Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903 [TBL] [Abstract][Full Text] [Related]
9. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations. Weber B; Rösel M; Arch R; Möller P; Zöller M Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925 [TBL] [Abstract][Full Text] [Related]
10. CD44s and CD44v6 expression in head and neck epithelia. Mack B; Gires O PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874 [TBL] [Abstract][Full Text] [Related]
11. Expression of the transmembrane glycoprotein CD44 and metastasis associated 18A2/MTS1 gene in B16 murine melanoma cells. Lakshmi MS; Parker C; Sherbet GV Anticancer Res; 1997; 17(5A):3451-5. PubMed ID: 9413186 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003 [TBL] [Abstract][Full Text] [Related]
13. Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma. Hong RL; Pu YS; Hsieh TS; Chu JS; Lee WJ J Urol; 1995 Jun; 153(6):2025-8. PubMed ID: 7538603 [TBL] [Abstract][Full Text] [Related]
14. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer. Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice. Fichtner I; Dehmel A; Naundorf H; Finke LH Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216 [TBL] [Abstract][Full Text] [Related]
16. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Wang SJ; Wreesmann VB; Bourguignon LY Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589 [TBL] [Abstract][Full Text] [Related]
17. Splice variants of CD44 in human cervical cancer stage IB to IIB. Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231 [TBL] [Abstract][Full Text] [Related]
19. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811 [TBL] [Abstract][Full Text] [Related]
20. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]